All treatments
Treatment
insulin icodec 700 U/mL PDS290 clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic confirmatory (Phase III)
A single arm study investigating the glycaemic control and safety of adding semaglutide to insulin icodec in participants with type 2 diabetes qualifying for treatment intensification.
This study looks at how well a new combination of medicines, semaglutide and insulin icodec, works for people with type 2 diabetes. It checks if this combination helps control blood sugar levels and if it's safe to use when current treatments aren't enough.
For: Diabetes Type 2Poland · Czechia - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Study to Evaluate the Efficacy and Safety of Once-weekly Insulin Icodec when Switching from Daily Basal Insulins Compared to Once-daily Insulin Glargine U100 in Adults with Type 2 Diabetes
This study is looking at a new once-a-week insulin treatment, called insulin icodec, for people with type 2 diabetes. It's comparing it to a daily insulin, Lantus, to see if the weekly option is safe and works just as well to control blood sugar.
For: Type 2 DiabetesPoland · Spain · Bulgaria